Klimadynon

Dry Extract From Cimicifuga Racemosa (L.) Nutt., Rhizoma (Black Cohosh) (5-10:1), Extraction Solvent, the active ingredient in Klimadynon, is a herbal botanical presented as a dry botanical extract for oral use. It is traditionally employed to support women experiencing menopausal and perimenopausal symptoms such as hot flashes, mood changes, and sleep disturbances.

GNH USA supplies Klimadynon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Klimadynon, a black‑cohosh extract, is used within the menopausal symptom management pathway. - Menopause: reduces frequency and intensity of hot flashes. - Perimenopausal mood swings: helps improve emotional stability. - Menstrual discomfort: may lessen cramping and dysmenorrhea. - Perimenopausal insomnia: supports better sleep quality.

Klimadynon is generally well tolerated, but users may experience adverse reactions.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or light‑headedness. - Skin rash or mild itching. - Fatigue or general weakness.

Serious or Rare Side Effects: - Hepatotoxicity: signs of liver injury such as jaundice. - Severe allergic reaction: swelling, breathing difficulty. - Thromboembolic events: rare clotting disorders. - Persistent hypertension. - Unexplained bleeding or bruising.

Before using Klimadynon, consider the following safety measures. - Liver disease: avoid if you have known hepatic impairment. - Pregnancy and breastfeeding: safety not established; consult a healthcare professional. - Hormone‑sensitive conditions: use with caution in estrogen‑dependent disorders. - Concomitant anticoagulant therapy: monitor for increased bleeding risk. - Allergies: discontinue if signs of hypersensitivity appear. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Klimadynon may interact with other medicines; awareness of potential interactions is important.

Major Interactions (Avoid): - Warfarin or other anticoagulants: increased bleeding risk. - Hormone replacement therapy: possible additive estrogenic effects.

Moderate Interactions (Monitor Closely): - CYP450 substrates (e.g., certain antidepressants): may alter drug metabolism. - Antihypertensive agents: potential additive blood‑pressure lowering. - Herbal supplements with similar serotonergic activity: risk of serotonin syndrome. - Immunosuppressants: possible modulation of immune response.